Insurers and employers are expected to be reluctant or even unable to immediately begin charging copays or deductibles for the affected preventive care for certain services, such as screening for diabetes, hepatitis and certain cancers.

Many insurers are offering smaller networks of doctors and hospitals, and problems arise when patients cannot find local in-network providers and must pay more for out-of-network care or travel farther for in-network care.

If half of adults get COVID boosters at the new, higher prices, insurers, employers, and other payors would shell out $12.4 billion to $14.8 billion a year, a recent KFF report estimated.

The latest twist in a long-running dispute between the drug industry and insurers over which group is more to blame for rising costs to patients. And patients are, again, caught in the middle.

Judge Reed O'Connor of the U.S. District Court for the Northern District of Texas says one way that preventive services are selected for the no-cost coverage is unconstitutional.

Health insurers are posting their negotiated rates for just about every type of medical service they cover across all providers.

Tens of thousands of employers who buy insurance coverage for their workers will get this more-complete pricing picture — and may not like what they see.

The move by some insurers to cut commissions as of April 1 has caught the attention not only of brokers but of federal regulators.